Owen Mumford Awarded New Three-Year Supply Agreement with Sanofi Aventis

Date published: 08 December 2009

Owen Mumford, one of the UK’s leading manufacturers of medical devices for diabetes, has just signed a new three-year supply agreement with Sanofi Aventis, thereby resuming this strong business partnership. Owen Mumford has earned a global reputation for providing some of the world’s finest diabetes products and has customers based worldwide.

The contract is for the supply of the Autopen 24 reusable insulin pen for use with Sanofi Aventis’ insulin cartridges, which will then be supplied to in excess of 60 different countries.

Adam Mumford, Sales & Marketing Director at Owen Mumford, said:

“This new agreement with Sanofi Aventis is a strong endorsement of the ease of use and effectiveness of Autopen 24 in assisting patients in the management of their diabetes, acknowledged by healthcare professionals and patients alike.  Sanofi Aventis wants to provide maximum patient choice in the selection of the most appropriate insulin pen to suit individual needs and our partnership helps them achieve this goal."